These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11786529)

  • 1. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
    Baroudi G; Acharfi S; Larouche C; Chahine M
    Circ Res; 2002 Jan; 90(1):E11-6. PubMed ID: 11786529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G).
    Baroudi G; Pouliot V; Denjoy I; Guicheney P; Shrier A; Chahine M
    Circ Res; 2001 Jun; 88(12):E78-83. PubMed ID: 11420310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
    Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
    Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation.
    Wan X; Wang Q; Kirsch GE
    J Mol Cell Cardiol; 2000 Oct; 32(10):1873-84. PubMed ID: 11013131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
    Makita N; Mochizuki N; Tsutsui H
    Circ J; 2008 Jun; 72(6):1018-9. PubMed ID: 18503232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
    Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
    Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H; Shimizu M; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.
    Watanabe H; Nogami A; Ohkubo K; Kawata H; Hayashi Y; Ishikawa T; Makiyama T; Nagao S; Yagihara N; Takehara N; Kawamura Y; Sato A; Okamura K; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Shimizu W; Makita N
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOG1: a new susceptibility gene for Brugada syndrome.
    Kattygnarath D; Maugenre S; Neyroud N; Balse E; Ichai C; Denjoy I; Dilanian G; Martins RP; Fressart V; Berthet M; Schott JJ; Leenhardt A; Probst V; Le Marec H; Hainque B; Coulombe A; Hatem SN; Guicheney P
    Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
    Wang DW; Makita N; Kitabatake A; Balser JR; George AL
    Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mechanism associated with idiopathic ventricular fibrillation (IVF) mutations R1232W and T1620M in human cardiac sodium channels.
    Vilin YY; Fujimoto E; Ruben PC
    Pflugers Arch; 2001 May; 442(2):204-11. PubMed ID: 11417215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in domain I of SCN5A cause Brugada syndrome.
    Vatta M; Dumaine R; Antzelevitch C; Brugada R; Li H; Bowles NE; Nademanee K; Brugada J; Brugada P; Towbin JA
    Mol Genet Metab; 2002 Apr; 75(4):317-24. PubMed ID: 12051963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.
    Itoh H; Shimizu M; Takata S; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 May; 16(5):486-93. PubMed ID: 15877619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.
    Makita N; Shirai N; Wang DW; Sasaki K; George AL; Kanno M; Kitabatake A
    Circulation; 2000 Jan 4-11; 101(1):54-60. PubMed ID: 10618304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.
    Hu D; Barajas-Martinez H; Burashnikov E; Springer M; Wu Y; Varro A; Pfeiffer R; Koopmann TT; Cordeiro JM; Guerchicoff A; Pollevick GD; Antzelevitch C
    Circ Cardiovasc Genet; 2009 Jun; 2(3):270-8. PubMed ID: 20031595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells.
    Baroudi G; Carbonneau E; Pouliot V; Chahine M
    FEBS Lett; 2000 Feb; 467(1):12-6. PubMed ID: 10664447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
    Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
    J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.
    Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M
    Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.